Home › Mild Cognitive Impairment › NCT07852650

Digital STEADI Efficacy

Randomized Control Trial to Test the Efficacy of the Digital STEADI Program.

Who can join

Ages 50 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Montreal Cognitive Assessment (MoCA) score between 26 and 30
* Able to walk independently with or without an assistive device.
* Able to rise independently from a standard desk or dining room chair without arms.
* Live independently in a non-institutional or senior community setting.
* Able to speak, hear and understand English
* Have 20/40 vision from 10 ft with or without correction (e.g., glasses)
* Willing to participate in the requirements of the research program.
* Able to meet in a physical study location on Emory campus.
* Screen positive for fall risk per the Stay Independent screener.

Exclusion Criteria:

* acute medical illness requiring hospitalization.
* hospitalized in the past 1 month.
* diagnosed with dementia (ADRD) or a neurodegenerative disease other than MCI (e.g., Parkinson's, multiple sclerosis).
* uncontrolled congestive heart failure (requiring hospitalization in the past year and/or unable to the equivalent of one city block).
* history of hospitalization for stroke in the past 1 year.
* inability to perform study procedures.

About the study

The aging of the U.S. population, combined with health care workforce shortages and insufficient access to effective fall prevention and exercise programs, has contributed to a high burden of fall-related injuries in older adults, especially in those with Mild Cognitive Impairment (MCI), a precursor of Alzheimer's dementia (AD) and related dementias (ADRD). There is an urgent need for scalable, evidence-based interventions that can be delivered efficiently in the home setting. This study aims to evaluate the efficacy and impact of a comprehensive digital fall prevention program (Digital STEADI) delivered through a technology platform with two conversational agents that leverage generative artificial intelligence (gen-AI) with human oversight to increase program access, enhance adherence to clinical fall prevention protocols and best practices, and reduce fall risk among community-dwelling older adults.

What is being tested

• Digital STEADI-1 (behavioral)
• STEADI Standard of Care (behavioral)
• Digital STEADI-2 (behavioral)
• Attentional control (behavioral)

Sponsor: Friendi.fi Corporation · Participants: 300 · Started: Sep 4, 2026

Contact the study team

• Chantal Kerssens, MSc, PhD · Phone: 404-282-0378

Official record on ClinicalTrials.gov — NCT07852650

Locations in the U.S.

Conditions

• Mild Cognitive Impairment

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.